These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 23432384)

  • 1. Ketamine for chronic pain: risks and benefits.
    Niesters M; Martini C; Dahan A
    Br J Clin Pharmacol; 2014 Feb; 77(2):357-67. PubMed ID: 23432384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Side effects of ketamine in the long-term treatment of neuropathic pain.
    Cvrcek P
    Pain Med; 2008 Mar; 9(2):253-7. PubMed ID: 18298710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain.
    Swartjes M; Morariu A; Niesters M; Aarts L; Dahan A
    Anesthesiology; 2011 Jul; 115(1):165-74. PubMed ID: 21606828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of ketamine in complex regional pain syndrome: possible mechanisms.
    Schwartzman RJ; Alexander GM; Grothusen JR
    Expert Rev Neurother; 2011 May; 11(5):719-34. PubMed ID: 21539489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain.
    Leung A; Wallace MS; Ridgeway B; Yaksh T
    Pain; 2001 Mar; 91(1-2):177-87. PubMed ID: 11240090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Parenteral administration of low dose ketamine for the treatment of neuropathic pain in cancer patients].
    Kong PE; Snijdelaar DG; Crul BJ
    Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2556-8. PubMed ID: 12532671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketamine for chronic noncancer pain: concerns regarding toxicity.
    Bell RF
    Curr Opin Support Palliat Care; 2012 Jun; 6(2):183-7. PubMed ID: 22436323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the use of ketamine in pain management.
    Tawfic QA
    J Opioid Manag; 2013; 9(5):379-88. PubMed ID: 24353050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic effect of subanesthetic intravenous ketamine in refractory neuropathic pain: a case report.
    Elsewaisy O; Slon B; Monagle J
    Pain Med; 2010 Jun; 11(6):946-50. PubMed ID: 20624244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preemptive ketamine during general anesthesia for postoperative analgesia in patients undergoing laparoscopic cholecystectomy.
    Launo C; Bassi C; Spagnolo L; Badano S; Ricci C; Lizzi A; Molinino M
    Minerva Anestesiol; 2004 Oct; 70(10):727-34; 734-8. PubMed ID: 15516884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine-A Narrative Review of Its Uses in Medicine.
    Radvansky BM; Puri S; Sifonios AN; Eloy JD; Le V
    Am J Ther; 2016; 23(6):e1414-e1426. PubMed ID: 25923225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine in pain management.
    Cohen SP; Liao W; Gupta A; Plunkett A
    Adv Psychosom Med; 2011; 30():139-161. PubMed ID: 21508630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of oral ketamine for the relief of intractable chronic pain: A retrospective 5-year study of 51 patients.
    Marchetti F; Coutaux A; Bellanger A; Magneux C; Bourgeois P; Mion G
    Eur J Pain; 2015 Aug; 19(7):984-93. PubMed ID: 25381898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can gradual dose titration of ketamine for management of neuropathic pain prevent psychotomimetic effects in patients with advanced cancer?
    Okamoto Y; Tsuneto S; Tanimukai H; Matsuda Y; Ohno Y; Tsugane M; Uejima E
    Am J Hosp Palliat Care; 2013 Aug; 30(5):450-4. PubMed ID: 22833552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain.
    Rabben T; Skjelbred P; Oye I
    J Pharmacol Exp Ther; 1999 May; 289(2):1060-6. PubMed ID: 10215688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride.
    Felsby S; Nielsen J; Arendt-Nielsen L; Jensen TS
    Pain; 1996 Feb; 64(2):283-291. PubMed ID: 8740606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic administration of ketamine for analgesia.
    Ben-Ari A; Lewis MC; Davidson E
    J Pain Palliat Care Pharmacother; 2007; 21(1):7-14. PubMed ID: 17430824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine for cancer pain: what is the evidence?
    Jonkman K; van de Donk T; Dahan A
    Curr Opin Support Palliat Care; 2017 Jun; 11(2):88-92. PubMed ID: 28306568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of prolonged outpatient ketamine infusions for neuropathic pain.
    Webster LR; Walker MJ
    Am J Ther; 2006; 13(4):300-5. PubMed ID: 16858163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine.
    Sinner B; Graf BM
    Handb Exp Pharmacol; 2008; (182):313-33. PubMed ID: 18175098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.